Ep127: Jeb Keiper on Computational Drug Discovery
The Long Run with Luke Timmerman - Un pódcast de Timmerman Report
Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.
